We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+15.99%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.57B
AUM Growth
+$240M
Cap. Flow
-$1.33M
Cap. Flow %
-0.05%
Top 10 Hldgs %
34.11%
Holding
1,211
New
84
Increased
525
Reduced
539
Closed
63

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$18.8M
2
LIN icon
Linde
LIN
+$15.3M
3
AVGO icon
Broadcom
AVGO
+$2.95M
4
AMD icon
Advanced Micro Devices
AMD
+$2.59M
5
HD icon
Home Depot
HD
+$1.46M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$6.03M
2
MSFT icon
Microsoft
MSFT
+$5.38M
3
CVX icon
Chevron
CVX
+$4.36M
4
META icon
Meta Platforms (Facebook)
META
+$4.08M
5
AAPL icon
Apple
AAPL
+$3.64M

Sector Composition

Rank Sector Weight
1 Technology 42.5%
2 Healthcare 12.67%
3 Consumer Discretionary 11.07%
4 Communication Services 9.14%
5 Financials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACAD icon
326
Acadia Pharmaceuticals
ACAD
$4.37B
$1.15M 0.04%
61,930
-8,539
-12% -$212K
SAGE
327
DELISTED
Sage Therapeutics
SAGE
$1.14M 0.04%
60,583
+10,870
+22% +$251K
TT icon
328
Trane Technologies
TT
$105B
$1.13M 0.04%
3,780
+828
+28% +$225K
CIEN icon
329
Ciena
CIEN
$52.1B
$1.12M 0.04%
22,606
-1,082
-5% -$57.1K
PNC icon
330
PNC Financial Services
PNC
$99.3B
$1.12M 0.04%
6,913
-372
-5% -$56.1K
VRDN icon
331
Viridian Therapeutics
VRDN
$2.19B
$1.1M 0.04%
63,011
+30,020
+91% +$582K
TME icon
332
Tencent Music
TME
$15.3B
$1.1M 0.04%
97,947
-42,132
-30% -$413K
INBX
333
DELISTED
Inhibrx, Inc. Common Stock
INBX
$1.1M 0.04%
31,335
+14,211
+83% +$518K
WFRD icon
334
Weatherford International
WFRD
$6.22B
$1.1M 0.04%
9,489
+494
+5% +$50.1K
BDX icon
335
Becton Dickinson
BDX
$44B
$1.09M 0.04%
4,420
-542
-11% -$130K
SIRI icon
336
SiriusXM
SIRI
$10.6B
$1.09M 0.04%
28,103
-1,608
-5% -$76.5K
BMEA icon
337
Biomea Fusion
BMEA
$91.8M
$1.09M 0.04%
72,877
+56,350
+341% +$928K
LSCC icon
338
Lattice Semiconductor
LSCC
$16.5B
$1.08M 0.04%
13,859
+2,791
+25% +$200K
PTGX icon
339
Protagonist Therapeutics
PTGX
$8.77B
$1.08M 0.04%
37,475
+9,585
+34% +$261K
IBRX icon
340
ImmunityBio
IBRX
$7.3B
$1.08M 0.04%
201,343
+81,386
+68% +$369K
PBR icon
341
Petrobras
PBR
$117B
$1.08M 0.04%
71,082
-12,378
-15% -$201K
MCK icon
342
McKesson
MCK
$99.8B
$1.08M 0.04%
2,008
-267
-12% -$136K
NOC icon
343
Northrop Grumman
NOC
$78B
$1.08M 0.04%
2,246
+229
+11% +$105K
VCYT icon
344
Veracyte
VCYT
$4.45B
$1.07M 0.04%
48,320
+21,388
+79% +$522K
SAP icon
345
SAP
SAP
$202B
$1.07M 0.04%
5,478
-768
-12% -$136K
FDX icon
346
FedEx
FDX
$73.8B
$1.06M 0.04%
3,664
+373
+11% +$93.3K
CTVA icon
347
Corteva
CTVA
$58.6B
$1.05M 0.04%
18,212
-1,099
-6% -$56.8K
HCA icon
348
HCA Healthcare
HCA
$86.2B
$1.04M 0.04%
3,121
-88
-3% -$26.9K
KURA icon
349
Kura Oncology
KURA
$923M
$1.04M 0.04%
48,682
+23,094
+90% +$449K
EMR icon
350
Emerson Electric
EMR
$82.9B
$1.03M 0.04%
9,105
+998
+12% +$103K
12 13
14
15 16

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Profund Advisors held 1,211 positions worth $2.57B, up 10% from $2.33B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Profund Advisors's Q1 2024 filing shows 84 new, 525 increased, 539 reduced and 63 closed positions. Its largest new stake was Altimmune: 134,842 shares worth $1.37M. The largest sale was ExxonMobil, an estimated $6.03M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Profund Advisors's largest Q1 2024 buy was Altimmune: 134,842 shares worth $1.37M.
  • Profund Advisors added most to NVIDIA in Q1 2024, an estimated $18.8M increase.
  • Profund Advisors's biggest Q1 2024 reduction was ExxonMobil, cutting an estimated $6.03M.
  • Profund Advisors fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $2.18M.
  • Profund Advisors's ten largest holdings make up 34% of its $2.57B portfolio in Q1 2024.
  • Profund Advisors opened 84 new positions and closed 63 in Q1 2024.
  • Profund Advisors's portfolio value rose 10% quarter-over-quarter to $2.57B.

Based on Profund Advisors's 13F filing for Q1 2024, filed 8 May 2024.